Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomas in Vitro-Reference-Cited by-同舟云学术

Evidence for Differential Effects of Selective Somatostatin Receptor Subtype Agonists on α-Subunit and Chromogranin A Secretion and on Cell Viability in Human Nonfunctioning Pituitary Adenomas in Vitro

Published:2004-10-01 Issue:10 Volume:89 Page:5181-5188
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Zatelli Maria Chiara¹,Piccin Daniela¹,Bottoni Arianna¹,Ambrosio Maria Rosaria¹,Margutti Angelo¹,Padovani Roberto²,Scanarini Massimo³,Taylor John E.⁴,Culler Michael D.⁴,Cavazzini Luigi⁵,degli Uberti Ettore C.¹

Affiliation:

1. Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies (M.C.Z., D.P., A.B., M.R.A., A.M., E.C.d.U.), 44100 Ferrara, Italy;

2. Division of Neurosurgery (R.P.), Hospital of Ferrara, 44100 Ferrara, Italy;

3. Division of Neurosurgery (M.S.), Hospital of Padova, 35100 Padova, Italy;

4. Biomeasure Incorporated/IPSEN (J.E.T., M.D.C.), Milford, Massachusetts 01757-3650

5. Department of Experimental and Diagnostic Medicine, Section of Anatomic Pathology (L.C.), University of Ferrara, 44100 Ferrara, Italy;

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/89/10/5181/10772019/jcem5181.pdf

Reference34 articles.

1. Somatostatin and its receptor family.;Patel;Front Neuroendocrinol,1999

2. Somatostatin receptor subtype specificity in human fetal pituitary cultures;Shimon;Differential role of SSTR2 and SSTR5 for growth hormone, thyroid stimulating hormone, and prolactin regulation. J Clin Invest,1997

3. Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.;Jaquet;J Clin Endocrinol Metab,2000

4. Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion.;Zatelli;J Clin Endocrinol Metab,2003

5. SOM230: a new somatostatin peptidomimetic with broad SRIF receptor binding and a unique inhibitory profile.;Bruns;Eur J Endocrinol,2002

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin receptors and the associated intracellular machinery: the two sides of the coin;Journal of Endocrinology;2024-01-15

2. Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects;Cancers;2021-04-10

3. Quantitative Analysis of Somatostatin and Dopamine Receptors Gene Expression Levels in Non-functioning Pituitary Tumors and Association with Clinical and Molecular Aggressiveness Features;Journal of Clinical Medicine;2020-09-22

4. Somatostatin receptor expression and patients’ response to targeted medical treatment in pituitary tumors: evidences and controversies;Journal of Endocrinological Investigation;2020-06-18

5. A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors;Clinical Cancer Research;2019-10-17